Cargando…

Low MT‐CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease

BACKGROUND: Cytochrome oxidase (COX) IV complex regulates energy production in mitochondria. Impaired COX gene expression is related to obesity and type 2 diabetes mellitus, but whether it is directly related to the incidence of cardiovascular events is unknown. We investigated whether COX gene expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Holvoet, Paul, Vanhaverbeke, Maarten, Bloch, Katarzyna, Baatsen, Pieter, Sinnaeve, Peter, Janssens, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210432/
https://www.ncbi.nlm.nih.gov/pubmed/27919931
http://dx.doi.org/10.1161/JAHA.116.004207
_version_ 1782490886230245376
author Holvoet, Paul
Vanhaverbeke, Maarten
Bloch, Katarzyna
Baatsen, Pieter
Sinnaeve, Peter
Janssens, Stefan
author_facet Holvoet, Paul
Vanhaverbeke, Maarten
Bloch, Katarzyna
Baatsen, Pieter
Sinnaeve, Peter
Janssens, Stefan
author_sort Holvoet, Paul
collection PubMed
description BACKGROUND: Cytochrome oxidase (COX) IV complex regulates energy production in mitochondria. Impaired COX gene expression is related to obesity and type 2 diabetes mellitus, but whether it is directly related to the incidence of cardiovascular events is unknown. We investigated whether COX gene expression in monocytes is predictive for cardiovascular events in coronary artery disease patients. To avoid monocyte isolation from fresh blood, we then aimed to validate our findings in monocyte‐derived microvesicles isolated from plasma. METHODS AND RESULTS: We enrolled 142 consecutive patients undergoing diagnostic coronary angiography between June 2010 and January 2011 and followed 67 patients with stable coronary artery disease prospectively for at least 3 years. Twenty‐two patients experienced a new cardiovascular event (32.8%). Circulating CD14(+) monocytes and microvesicles were isolated with magnetic beads, and COX mRNA levels were measured with quantitative polymerase chain reaction, after normalization with 5 validated house‐keeping genes. Patients in the lowest tertile of mitochondrial cytochrome oxidase, subunit I (MT‐COI) in monocytes at baseline had a higher risk for developing a new event after adjusting for age, sex, (ex)smoking, body mass index, blood pressure, diabetes mellitus, low‐density lipoprotein– and high‐density lipoprotein–cholesterol, triglycerides, high‐sensitivity C‐reactive protein, interleukin‐6, and number of diseased vessels (harzard ratio [HR], 3.95; 95% CI, 1.63–9.57). Patients in the lowest tertile of MT‐COI in monocyte‐specific microvesicles had also a higher risk of developing a new event (adjusted HR, 5.00; 95% CI, 1.77–14). CONCLUSIONS: In the current blinded study, low MT‐COI in monocytes of coronary artery disease patients identifies a population at risk for new cardiovascular events. For the first time, we show that signatures in monocyte‐specific microvesicles in plasma have similar predictive properties.
format Online
Article
Text
id pubmed-5210432
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-52104322017-01-05 Low MT‐CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease Holvoet, Paul Vanhaverbeke, Maarten Bloch, Katarzyna Baatsen, Pieter Sinnaeve, Peter Janssens, Stefan J Am Heart Assoc Original Research BACKGROUND: Cytochrome oxidase (COX) IV complex regulates energy production in mitochondria. Impaired COX gene expression is related to obesity and type 2 diabetes mellitus, but whether it is directly related to the incidence of cardiovascular events is unknown. We investigated whether COX gene expression in monocytes is predictive for cardiovascular events in coronary artery disease patients. To avoid monocyte isolation from fresh blood, we then aimed to validate our findings in monocyte‐derived microvesicles isolated from plasma. METHODS AND RESULTS: We enrolled 142 consecutive patients undergoing diagnostic coronary angiography between June 2010 and January 2011 and followed 67 patients with stable coronary artery disease prospectively for at least 3 years. Twenty‐two patients experienced a new cardiovascular event (32.8%). Circulating CD14(+) monocytes and microvesicles were isolated with magnetic beads, and COX mRNA levels were measured with quantitative polymerase chain reaction, after normalization with 5 validated house‐keeping genes. Patients in the lowest tertile of mitochondrial cytochrome oxidase, subunit I (MT‐COI) in monocytes at baseline had a higher risk for developing a new event after adjusting for age, sex, (ex)smoking, body mass index, blood pressure, diabetes mellitus, low‐density lipoprotein– and high‐density lipoprotein–cholesterol, triglycerides, high‐sensitivity C‐reactive protein, interleukin‐6, and number of diseased vessels (harzard ratio [HR], 3.95; 95% CI, 1.63–9.57). Patients in the lowest tertile of MT‐COI in monocyte‐specific microvesicles had also a higher risk of developing a new event (adjusted HR, 5.00; 95% CI, 1.77–14). CONCLUSIONS: In the current blinded study, low MT‐COI in monocytes of coronary artery disease patients identifies a population at risk for new cardiovascular events. For the first time, we show that signatures in monocyte‐specific microvesicles in plasma have similar predictive properties. John Wiley and Sons Inc. 2016-12-05 /pmc/articles/PMC5210432/ /pubmed/27919931 http://dx.doi.org/10.1161/JAHA.116.004207 Text en © 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Holvoet, Paul
Vanhaverbeke, Maarten
Bloch, Katarzyna
Baatsen, Pieter
Sinnaeve, Peter
Janssens, Stefan
Low MT‐CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease
title Low MT‐CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease
title_full Low MT‐CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease
title_fullStr Low MT‐CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease
title_full_unstemmed Low MT‐CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease
title_short Low MT‐CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease
title_sort low mt‐co1 in monocytes and microvesicles is associated with outcome in patients with coronary artery disease
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210432/
https://www.ncbi.nlm.nih.gov/pubmed/27919931
http://dx.doi.org/10.1161/JAHA.116.004207
work_keys_str_mv AT holvoetpaul lowmtco1inmonocytesandmicrovesiclesisassociatedwithoutcomeinpatientswithcoronaryarterydisease
AT vanhaverbekemaarten lowmtco1inmonocytesandmicrovesiclesisassociatedwithoutcomeinpatientswithcoronaryarterydisease
AT blochkatarzyna lowmtco1inmonocytesandmicrovesiclesisassociatedwithoutcomeinpatientswithcoronaryarterydisease
AT baatsenpieter lowmtco1inmonocytesandmicrovesiclesisassociatedwithoutcomeinpatientswithcoronaryarterydisease
AT sinnaevepeter lowmtco1inmonocytesandmicrovesiclesisassociatedwithoutcomeinpatientswithcoronaryarterydisease
AT janssensstefan lowmtco1inmonocytesandmicrovesiclesisassociatedwithoutcomeinpatientswithcoronaryarterydisease